EFORT CONGRESS HAMBURG 2024 | EXHIBITORS IN HAMBURG

Nested Applications

HAM24 EXHIB DATABASE BLURB

EXHIBITORS AND SPONSORS LISTING EFORT CONGRESS HAMBURG 2024

EFORT invites you to browse through the Exhibitors Database of the 25th EFORT Annual Congress Hamburg 2024 which represents those exhibitors that have already committed to and confirmed their presence at the EFORT Congress to be held in Hamburg, Germany from 22 to 24 May 2024. 

Should you wish to exhibit, please check the online EFORT WEBSHOP.

EFORT Industry Database


Maxxeus

2900 College Dr.
OH 45420 Kettering
United States
Phone: +1(800) 684-7783
About Us

Welcome to Maxxeus, the biologic solutions surgeons prefer, delivering the trusted results they expect. Maxxeus biologics have been available since 1990 and provide safe and high-quality options for the best surgical outcome. With decades of expertise in providing biologics to the orthopedic market, we understand the needs of the implanting surgeon. Because we focus exclusively on biologics, Maxxeus can provide our customers and their patients the best regenerative biologics options available.

We provide a large portfolio of allograft tissue that have been developed specifically to meet our customer’s needs. With a robust Process, Engineering and Development program, Maxxeus uses science and innovation to develop the newest technologies. Our portfolio continues to expand as innovative technologies develop and techniques evolve. With a dedicated customer service team and sales representatives around the globe, we provide premier service to all our customers no matter the size of your practice.

Maxxeus is a brand of Solvita, a not-for-profit tissue bank, located in Dayton, Ohio. Solvita is registered with the Food and Drug Administration (FDA), accredited by the American Association of Tissue Banks (AATB) and maintains all applicable state licenses.

Solvita’s Kettering - Research Park location is ISO 13485 certified. The facility is one of the most advanced in the world and is devoted exclusively to the research, production and distribution of allografts. Designed and built from the ground up with quality and safety in mind, the building houses thirty class 100 clean rooms and over 5,000 square feet of research and development space.

For more information on Solvita, please visit www.solvita.org.

Area of Business: Orthopaedic Industry
Category: Allografts
Number of Employees worldwide: 1,001 - 5,000 employees
Founded in: 1990
Products
No products found.
Please contact us by e-Mail to request a meeting.

Nested Applications

HAM24 WebShop banner


Nested Applications

ARE YOU EXHIBITING?

ARE YOU EXHIBITING AT EFORT 2024?

Feel free to use these templates to announce your presence as an exhibitor at the EFORT Congress.
Find two versions available for your social media (Instagram/Facebook and Twitter/LinkedIn formats) .

 

 

Find more resources at the
EFORT Congress Resource Center

 

HAM24 Compliance Blurb

Ethical MedTech Compliance
 


EFORT is recognised as "Compliant" on the Ethical MedTech Platform for its 25th EFORT Congress taking place in Hamburg, Germany, from the 22 to the 24 May 2024. Thanks to all our corporate partners already attending - we look forward to seeing you there!

HAM24 Scientific Programme banner Square

EFORT Annual Congress: Past Exhibitors

Past EFORT Congresses Exhibitors

EFORT understands that in order to assess the relevance of your company exhibiting during our EFORT Congresses – it is often useful to see which companies have exhibited at previous EFORT congresses. For your convenience, therefore, please find the complete exhibitor listings for the following annual congresses via the links below:

For any inquiries relating to exhibition, satellites and sponsorship – please contact by using the official exhibitors and sponsorship contact us online form.

Note*: The global Covid-19 pandemic forced EFORT to take the difficult decision to postpone the 21st and 22nd EFORT Annual Congresses that was formerly planned to be held in Vienna, Austria in June 2020 and June-July 2021 respectively.